Pharma TV ads and R&D funding

By Forbes
| March 30, 2022

Heavyweights Pfizer, Novartis, and Lilly, and the smaller biopharma, Incyte had TV ads during the Oscars on Sunday. These ads weren’t cheap. Thirty second spots ran anywhere from $1.7 - $2.2 million.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...